Adage Capital Partners’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Adage Capital Partners’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-584,332	Closed	-$56.7M	–	792
2019 Q3	$56.7M	Hold	584,332	–	–	0.14%	182
2019 Q2	$59.8M	Buy	584,332 +34,332	+6%	+$3.7M	0.15%	178
2019 Q1	$62.6M	Buy	+550,000	New	+$40.4M	0.16%	167
2017 Q4	–	Sell	-290,800	Closed	-$25.9M	–	775
2017 Q3	$25.9M	Buy	+290,800	New	+$22.1M	0.06%	358
2015 Q4	–	Sell	-6,075	Closed	-$254K	–	758
2015 Q3	$254K	Buy	+6,075	New	+$317K	﹤0.01%	704

Adage Capital Partners's ONCE Position: Q4 2019 in Review

Adage Capital Partners sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 584,332 shares — an estimated $56.7M sold.

Adage Capital Partners first reported a position in ONCE in Q3 2015 and held it in 5 quarters. The position peaked at $62.6M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Adage Capital Partners reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Adage Capital Partners sold 584,332 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $56.7M.
Adage Capital Partners first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2015 and held it in 5 quarters.
Adage Capital Partners's Spark Therapeutics, Inc. Common Stock position peaked at $62.6M in Q1 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Adage Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.